Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
- 5 June 2012
- journal article
- Published by Elsevier BV in Virology
- Vol. 427 (2), 198-207
- https://doi.org/10.1016/j.virol.2012.02.003
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI077451, HL59725, AI082274, AI084119, AI27742, GM088118)
- Bill and Melinda Gates Foundation
- Department of Veterans Affairs
This publication has 58 references indexed in Scilit:
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Nature, 2011
- Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120Structure, 2011
- Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine designNature Reviews Immunology, 2010
- An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120Virology, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandThe New England Journal of Medicine, 2009
- Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based ImmunogensStructure, 2009
- Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1Molecular Immunology, 2009
- Structure prediction for CASP8 with all‐atom refinement using RosettaProteins, 2009
- Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibodyNature Structural & Molecular Biology, 2006
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997